Zobrazeno 1 - 10
of 10
pro vyhledávání: '"José V. González-Aramundiz"'
Autor:
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, Alejandro Piña-Iturbe, Mariana Ríos, Daniela Moreno-Tapia, Patricia Pereira-Sánchez, Diane Leighton, Claudia Orellana, Consuelo Covarrubias, Nicolás M.S. Gálvez, Jorge A. Soto, Luisa F. Duarte, Daniela Rivera-Pérez, Yaneisi Vázquez, Alex Cabrera, Sergio Bustos, Carolina Iturriaga, Marcela Urzua, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Felipe Melo-González, Susan M. Bueno, Alexis M. Kalergis, María Soledad Navarrete, Constanza Del Río, Dinely Del Pino, Natalia Aguirre, Grecia Salinas, Franco Vega, Acsa Salgado, Thomas Quinteros, Marlene Ortiz, Marcela Puente, Alma Muñoz, Patricio Astudillo, Nicole Le Corre, Marcela Potin, Juan Catalán, Melan Peralta, Consuelo Zamanillo, Nicole Keller, Rocío Fernández, Sofía Aljaro, Sofía López, José Tomás González, Tania Weil, Luz Opazo, Paula Muñoz, Inés Estay, Miguel Cantillana, Liliana Carrera, Matías Masalleras, Paula Guzmán, Francisca Aguirre, Aarón Cortés, Luis Federico Bátiz, Javiera Pérez, Karen Apablaza, Lorena Yates, María de los Ángeles Valdés, Bernardita Hurtado, Veronique Venteneul, Constanza Astorga, Paula Muñoz-Venturelli, Pablo A. Vial, Andrea Schilling, Daniela Pavez, Inia Pérez, Amy Riviotta, Francisca González, Francisca Urrutia, Alejandra Del Río, Claudia Asenjo, Bárbara Vargas, Francisca Castro, Alejandra Acuña, Javiera Guzmán, Camila Astudillo, Carlos M. Pérez, Pilar Espinoza, Andrea Martínez, Marcela Arancibia, Harold Romero, Cecilia Bustamante, María Loreto Pérez, Natalia Uribe, Viviana Silva, Bernardita Morice, Marco Pérez, Marcela González, Werner Jensen, Claudia Pasten, M. Fernanda Aguilera, Nataly Martínez, Camila Molina, Sebastián Arrieta, Begoña López, Claudia Ortiz, Macarena Escobar, Camila Bustamante, Marcia Espinoza, Angela Pardo, Alison Carrasco, Miguel Montes, Macarena Saldías, Natalia Gutiérrez, Juliette Sánchez, Daniela Fuentes, Yolanda Calvo, Mariela Cepeda, Rosario Lemus, Muriel Suárez, Mercedes Armijo, Shirley Monsalves, Constance Marucich, Cecilia Cornejo, Ángela Acosta, Xaviera Prado, Francisca Yáñez, Marisol Barroeta, Claudia López, Paulina Donato, Martin Lasso, María Iturrieta, Juan Giraldo, Francisco Gutiérrez, María Acuña, Ada Cascone, Raymundo Rojas, Camila Sepúlveda, Mario Contreras, Yessica Campisto, Pablo González, Zoila Quizhpi, Mariella López, Vania Pizzeghello, Stephannie Silva
Publikováno v:
EBioMedicine, Vol 91, Iss , Pp 104563- (2023)
Summary: Background: The Omicron variant has challenged the control of the COVID-19 pandemic due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 vaccine showed positive effects in the immunogenicity against SARS
Externí odkaz:
https://doaj.org/article/ada72f7a33e042e3b8078e201eaafcb4
Autor:
Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I. Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio Cárdenas, Eduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José V. González-Aramundiz, María Javiera Álvarez-Figueroa, Pablo A. González, Susan M. Bueno, Jorge A. Soto, on behalf of the PedCoronaVac03CL Study Group, Cecilia Perret, Alexis M. Kalergis
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1526 (2023)
During the COVID-19 pandemic, the importance of vaccinating children against SARS-CoV-2 was rapidly established. This study describes the safety of CoronaVac® in children and adolescents between 3- and 17-years-old in a multicenter study in Chile wi
Externí odkaz:
https://doaj.org/article/c5022dfe2bd44e14b220236ff2479bce
Autor:
Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A. Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I. Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V. González-Aramundiz, Nicole Le Corre, María Javiera Álvarez-Figueroa, Pablo A. González, Katia Abarca, Cecilia Perret, Leandro J. Carreño, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated vaccine Cor
Externí odkaz:
https://doaj.org/article/cf113e0121754f51995644752d348004
Autor:
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Jorge A. Soto, Roslye V. Berríos-Rojas, Liliana A. González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Catalina A. Andrade-Parra, Omar P. Vallejos, Alejandro Piña-Iturbe, Carolina Iturriaga, Marcela Urzua, María S. Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after two doses of CoronaVac; these leve
Externí odkaz:
https://doaj.org/article/0d12c0aeee20419bb5fc3ab69b554f1b
Autor:
Felipe Melo-González, Jorge A. Soto, Liliana A. González, Jorge Fernández, Luisa F. Duarte, Bárbara M. Schultz, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Mariana Ríos, Yaneisi Vázquez, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Carolina Iturriaga, Omar P. Vallejos, Roslye V. Berríos-Rojas, Guillermo Hoppe-Elsholz, Marcela Urzúa, Nicole Bruneau, Rodrigo A. Fasce, Judith Mora, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Eugenio Ramírez, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have emerged and some of them are associat
Externí odkaz:
https://doaj.org/article/13f78279cb1a4b92aeac29dc13bff0ae
Autor:
Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, Marcela Urzúa, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Gaspar A. Pacheco, Omar P. Vallejos, Guillermo Hoppe-Elsholz, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies conti
Externí odkaz:
https://doaj.org/article/4e8fbbc37cb647b0bcc16a6cfa23cc35
Autor:
Katia Abarca, Carolina Iturriaga, Marcela Urzúa, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, Pablo A. González, Susan M. Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M. Pérez, Marcela Potin, Álvaro Rojas, José V. González-Aramundiz, Nicolás M. S. Gálvez, Francisca Aguirre-Boza, Sofía Aljaro, Luis Federico Bátiz, Yessica Campisto, Mariela Cepeda, Aarón Cortés, Sofía López, María Loreto Pérez, Andrea Schilling, Alexis M. Kalergis, on behalf of the CoronaVac03CL Study Group
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1082 (2022)
Several vaccines have been developed to control the COVID-19 pandemic. CoronaVac®, an inactivated SARS-CoV-2 vaccine, has demonstrated safety and immunogenicity, preventing severe COVID-19 cases. We investigate the safety and non-inferiority of two
Externí odkaz:
https://doaj.org/article/cf5a17f62e894631ab713b4f3f4ddabd
Autor:
Katia Abarca, Emma Rey-Jurado, Natalia Muñoz-Durango, Yaneisi Vázquez, Jorge A. Soto, Nicolás M.S. Gálvez, Javier Valdés-Ferrada, Carolina Iturriaga, Marcela Urzúa, Arturo Borzutzky, Jaime Cerda, Luis Villarroel, Victoria Madrid, Pablo A. González, José V. González-Aramundiz, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
EClinicalMedicine, Vol 27, Iss , Pp 100517- (2020)
Background: Respiratory syncytial virus (RSV) is responsible for most respiratory tract infections and hospitalizations in infants and represents a significant economic burden for public health. The development of a safe, effective, and affordable va
Externí odkaz:
https://doaj.org/article/137eebfd82344a5b8e4a0a28a136c4d8
Autor:
Nicolás M S, Gálvez, Gaspar A, Pacheco, Bárbara M, Schultz, Felipe, Melo-González, Jorge A, Soto, Luisa F, Duarte, Liliana A, González, Daniela, Rivera-Pérez, Mariana, Ríos, Roslye V, Berrios, Yaneisi, Vázquez, Daniela, Moreno-Tapia, Omar P, Vallejos, Catalina A, Andrade, Guillermo, Hoppe-Elsholz, Carolina, Iturriaga, Marcela, Urzua, María S, Navarrete, Álvaro, Rojas, Rodrigo, Fasce, Jorge, Fernández, Judith, Mora, Eugenio, Ramírez, Aracelly, Gaete-Argel, Mónica L, Acevedo, Fernando, Valiente-Echeverría, Ricardo, Soto-Rifo, Daniela, Weiskopf, Alba, Grifoni, Alessandro, Sette, Gang, Zeng, Weining, Meng, José V, González-Aramundiz, Marina, Johnson, David, Goldblatt, Pablo A, González, Katia, Abarca, Susan M, Bueno, Alexis M, Kalergis
Publikováno v:
eLife. 11
Background:The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine approved for emer
Autor:
Bárbara M, Schultz, Felipe, Melo-González, Luisa F, Duarte, Nicolás Ms, Gálvez, Gaspar A, Pacheco, Jorge A, Soto, Roslye V, Berríos-Rojas, Liliana A, González, Daniela, Moreno-Tapia, Daniela, Rivera-Pérez, Mariana, Ríos, Yaneisi, Vázquez, Guillermo, Hoppe-Elsholz, Omar P, Vallejos, Carolina, Iturriaga, Marcela, Urzua, María S, Navarrete, Álvaro, Rojas, Rodrigo, Fasce, Jorge, Fernández, Judith, Mora, Eugenio, Ramírez, Aracelly, Gaete-Argel, Mónica, Acevedo, Fernando, Valiente-Echeverría, Ricardo, Soto-Rifo, Daniela, Weiskopf, Alba, Grifoni, Alessandro, Sette, Gang, Zeng, Weining, Meng, José V, González-Aramundiz, Pablo A, González, Katia, Abarca, Alexis M, Kalergis, Susan M, Bueno
Publikováno v:
medRxiv : the preprint server for health sciences.
BackgroundCoronaVac®is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization. Previous studies reported increased levels of neutralizing antibodies and specific T cells two- and four-weeks after two doses of CoronaVac®, but th